DNA RNA and Cells
21 November 2013
Oncolytics Biotech® Inc. Announces Positive Top-Line Data from REO 018 Randomized Study of REOLYSIN® in Head and Neck Cancers19 November 2013
Amgen Presents Interim Overall Survival Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma19 November 2013
Mesoblast’s Cell Therapy Strengthens Native Heart Function In Patients With End-Stage Heart Failure on Assisted Circulatory Support18 November 2013
Alnylam Presents New Pre-clinical Data on RNAi Therapeutics for Cardiovascular Disease at American Heart Association Meeting18 November 2013
Kiadis Pharma Provides Positive Update on its Phase II Clinical Program with Blood Cancer Treatment ATIR17 November 2013
Isis Pharmaceuticals Reports Positive Phase 1 Data Demonstrating ISIS-APO(a) Rx Produces Significant Reductions in Lp(a) Levels16 November 2013
AGTC and The University of Massachusetts Medical School Report Promising Phase II Gene Therapy Clinical Data15 November 2013
Sangamo BioSciences Announces Presentation Of Clinical Data From Alzheimer’s Disease Program14 November 2013
DNAtrix Announces Treatment of First Patient in Study with Recurrent Glioblastoma Using DNX-2401 and Temozolomide12 November 2013
Advanced Melanoma Patients’ Long-Term Survival Improved with California Stem Cell, Inc.’s Patient Specific Cell Therapy12 November 2013
Sangamo BioSciences Announces Presentation Of First Demonstration Of In Vivo Efficacy Of Novel ZFP Therapeutic® For Huntington’s Disease12 November 2013
Isis Pharmaceuticals Earns $1.5M from the Advancement of the Phase 2 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy12 November 2013
Promethera Biosciences successfully enrols twenty patients in its multicentric phase I/II trial8 November 2013
Regulus Presents Positive Preclinical Data Demonstrating that microRNA-21 Plays an Important Role in Alport Syndrome6 November 2013
Cellular Biomedicine Group Receives Approval for Phase IIb Clinical Trial of ReJoin™ for Treatment of Knee Osteoarthritis (KOA)4 November 2013
Arrowhead Presents Data Suggesting ARC-520 Induces Therapeutic Flare in Chronic Hepatitis B4 November 2013
Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients3 November 2013
Aastrom Announces Results of Two Studies of Ixmyelocel-T Published in Stem Cell Research & TherapyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports